Filtering by:
Hodgkin LymphomaYoung Adult Persists, Gets Help for Hodgkin Lymphoma
When Katie Dimmock, 26, learned she had cancer, she was actually a little relieved. “It was one of the worst – but at the same time best – moments,” said Dimmock.
FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.
New Cancer Drug Approvals From 2016
In 2016, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
FDA Approves Opdivo for Hard-to-Treat Hodgkin Lymphoma
The FDA granted accelerated approval to Opdivo (nivolumab) for Hodgkin lymphoma after treatment with stem cell transplant and post-transplant drug Adcentris.
X Scientists Predict Risk of Infertility in Women Treated for Hodgkin Disease
Doctors have long known that some women, especially younger women, develop fertility problems as a result of treatment for Hodgkin disease. Specifically, some treatments lead to early menopause, which reduces or takes away the ability to have children.
Survivor of Adolescent Cancer Takes Nothing for Granted
Julie Turner describes herself as an average 56-year-old woman, a mother and grandmother, a retired school administrator, an American Cancer Society volunteer, and a very lucky person. A survivor of Hodgkin Disease from age 17, Turner says she is amazed at everything she has in her life today.
Hodgkin Lymphoma Survivor Pours Her Energy into Volunteering
American Cancer Society Survivor Speaker Jemma Cabral tells audiences she hopes they never take another birthday for granted. A 2-time survivor of Hodgkin lymphoma, she certainly doesn’t.
Childhood Cancer Survivor Finds Her Voice
Since her treatment for Hodgkin lymphoma, Brianna Commerford has become a spokesperson for childhood cancer, spoken before Congress and raised $30,000 for the American Cancer Society.
